Welcome to the UPF Digital Repository

Prevalence of cardiovascular risk factors in people with epilepsy

Show simple item record

dc.contributor.author Vivanco Hidalgo, Rosa María
dc.contributor.author Gomez, Alejandra
dc.contributor.author Moreira Villanueva, Antía
dc.contributor.author Díez, Laura
dc.contributor.author Elosua Llanos, Roberto
dc.contributor.author Roquer, Jaume
dc.date.accessioned 2017-11-27T08:41:52Z
dc.date.available 2017-11-27T08:41:52Z
dc.date.issued 2016
dc.identifier.citation Vivanco-Hidalgo RM, Gomez A, Moreira A, Díez L, Elosua R, Roquer J. Prevalence of cardiovascular risk factors in people with epilepsy. Brain Behav. 2016 Dec 20;7(2):e00618. DOI: 10.1002/brb3.618
dc.identifier.issn 2162-3279
dc.identifier.uri http://hdl.handle.net/10230/33337
dc.description.abstract OBJECTIVES: Epilepsy has been associated with cardiovascular comorbidity. This study aimed to assess the potential association between cardiovascular risk factors (CRFs), antiepileptic drugs (AEDs), and etiology. MATERIAL AND METHODS: A single-center retrospective epilepsy cohort from the decade of 2004-2013 was assessed. Poisson regression models with robust variance were estimated to obtain CRF prevalence ratios (PR) according to AED prescription and etiology. RESULTS: After excluding patients in the monotherapy group with vascular etiology or previous cardiovascular events, in the remaining 400 patients, enzyme-inducer AEDs (EIAEDs), especially phenytoin (PHT), were associated with higher prevalence of dyslipidemia (PRa 1.77, p < .05), compared to valproic acid. No etiology was associated with higher prevalence of any CRF. CONCLUSIONS: Patients treated with EIAEDs, especially PHT, had higher prevalence of dyslipidemia.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Wiley
dc.rights Copyright © 2016 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the https://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
dc.subject.other Epilèpsia
dc.subject.other Cor -- Malalties
dc.title Prevalence of cardiovascular risk factors in people with epilepsy
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1002/brb3.618
dc.subject.keyword Antiepileptic drugs
dc.subject.keyword Cardiovascular risk factors
dc.subject.keyword Comorbidity
dc.subject.keyword Epilepsy
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account


Compliant to Partaking